This Article  • Full text  • PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Contact me when this article is cited  Related Content  • Similar articles in JAMA  Topic Collections  • Prostate Disease  • Oncology  • Prostate Cancer  • Treatment Adherence  • Patient-Physician Relationship, Other  • Evidence-Based Medicine  • Quality of Care, Other  • Alert me on articles by topic

Incorporating Patient Preferences

Murray Krahn, MD, MSc, FRCPC; Gary Naglie, MD, FRCPC

JAMA. 2008;300(4):436-438.

	Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

Clinical practice guidelines (CPGs) are systematically developed statements to assist both patient and practitioner decisions. A fixture of modern medical care, guidelines link the practice of medicine more closely to the body of underlying evidence, shift the burden of evidence review from the individual practitioner to experts, and aim to improve the quality of care.¹

But do guidelines take into account what patients want and value? Consider the following examples. A patient with mild to moderate hypertension has shown some lowering of blood pressure but has not achieved her guideline-recommended target with salt reduction, exercise, and weight reduction. After considering the potential risks and benefits, she prefers to avoid drugs and continue with her behavioral interventions. Another patient with atrial fibrillation prefers to begin taking warfarin rather than aspirin, even though he is at low risk of stroke. He is a . . . [Full Text of this Article]

Evidence on the Role of Preferences
in Guidelines

Finding Preference-Related Evidence

Integrating Preference-Related Evidence Into Recommendations

Using Guidelines in Individual Decision Making

Including Patients in the Guideline Development Process

Evaluating Guidelines With Preferences in Mind

Author Affiliations: Toronto Hospital (Dr Naglie); Toronto Health Economics and Technology Assessment Collaborative, Toronto General Research Institute, and University of Toronto (Dr Krahn), Toronto, Ontario, Canada.